Introduction
Critical Limb Ischemia - Overview
Critical Limb Ischemia - Therapeutics Development
Critical Limb Ischemia - Therapeutics Assessment
Critical Limb Ischemia - Companies Involved in Therapeutics Development
Critical Limb Ischemia - Drug Profiles
Critical Limb Ischemia - Dormant Projects
Critical Limb Ischemia - Discontinued Products
Critical Limb Ischemia - Product Development Milestonesh
Appendix

List of Tables
Number of Products under Development for Critical Limb Ischemia, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Critical Limb Ischemia - Pipeline by Ambulero Inc, 2021
Critical Limb Ischemia - Pipeline by Anaeropharma Science Inc, 2021
Critical Limb Ischemia - Pipeline by Antidote Therapeutics Inc, 2021
Critical Limb Ischemia - Pipeline by Athersys Inc, 2021
Critical Limb Ischemia - Pipeline by Caladrius Biosciences Inc, 2021
Critical Limb Ischemia - Pipeline by Constant Therapeutics LLC, 2021
Critical Limb Ischemia - Pipeline by Cynata Therapeutics Ltd, 2021
Critical Limb Ischemia - Pipeline by GPCR Therapeutics Inc, 2021
Critical Limb Ischemia - Pipeline by Gurus BioPharm, 2021
Critical Limb Ischemia - Pipeline by Helixmith Co Ltd, 2021
Critical Limb Ischemia - Pipeline by Hemostemix Inc, 2021
Critical Limb Ischemia - Pipeline by ID Pharma Co Ltd, 2021
Critical Limb Ischemia - Pipeline by Ixaka Ltd, 2021
Critical Limb Ischemia - Pipeline by Juventas Therapeutics Inc, 2021
Critical Limb Ischemia - Pipeline by Libella Gene Therapeutics, 2021
Critical Limb Ischemia - Pipeline by LifeCells LLC, 2021
Critical Limb Ischemia - Pipeline by New B Innovation Ltd, 2021
Critical Limb Ischemia - Dormant Projects, 2021
Critical Limb Ischemia - Discontinued Products, 2021

List of Figures
Number of Products under Development for Critical Limb Ischemia, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Top 10 Routes of Administration, 2021
Number of Products by Stage and Top 10 Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

Companies Mentioned
• Ambulero Inc
• Anaeropharma Science Inc
• Antidote Therapeutics Inc
• Athersys Inc
• Caladrius Biosciences Inc
• Constant Therapeutics LLC
• Cynata Therapeutics Ltd
• GPCR Therapeutics Inc
• Gurus BioPharm
• Helixmith Co Ltd
• Hemostemix Inc
• ID Pharma Co Ltd
• Ixaka Ltd
• Juventas Therapeutics Inc
• Libella Gene Therapeutics
• LifeCells LLC
• New B Innovation Ltd
• Pharmicell Co Ltd
• Pluristem Therapeutics Inc
• ReNeuron Group Plc
• Reven Pharmaceuticals Inc
• S.Biomedics Co Ltd
• Taiwan Bio Therapeutics Co Ltd
• Theratome Bio Inc
• U.S. Stem Cell Inc
• VESSL Therapeutics Ltd